At the news
? NEUTRALIMPACT 3/10 6-K filed Nov 20, 2026 at 09:25 ET
IM Cannabis Corp. appointed Ronen Zalayet as CEO and Ohad Melnik as independent director, succeeding Oren Shuster who resigned as CEO and director. The filing contains no financial results, guidance, or material operational data, it is a routine leadership and board transition.
- Ronen Zalayet appointed CEO effective November 19, 2026, succeeding Oren Shuster
- Oren Shuster resigned as CEO and director but remains a director of Israeli subsidiaries
- Ohad Melnik appointed independent director, subject to Israel Medical Cannabis Agency approval
- Shakked Shuster appointed CEO of Focus Medical Herbs Ltd., the Israeli subsidiary
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access